Content Hub

HUB Organoid Technology Interview

Exclusive Interview with Carla Verissimo, Head of Oncology II, HUB Organoid Technology


    • The biggest challenges being faced in modelling the TME, effectively assessing efficacy and boosting translational confidence
    • Why we are still facing these hurdles
    • The next steps the industry must take to overcome them in an exclusive interview